Previous issues
-
Previous issues
Volume 26(3) Jul 2020
Print ISSN: 2287-2728
Online ISSN: 2287-285X
- Special Topic Management of liver diseases during the pandemic of coronavirus disease-19
- Ju-Yeon Cho, Soon Sun Kim, Young-Sun Lee, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
- Clin Mol Hepatol. 2020;26(3):243-250.
- Reviews Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
- Chung-Feng Huang, Ming-Lung Yu
- Clin Mol Hepatol. 2020;26(3):251-260.
- Novel biomarkers for the management of chronic hepatitis B
- Takako Inoue, Yasuhito Tanaka
- Clin Mol Hepatol. 2020;26(3):261-279.
- Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis
- Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada
- Clin Mol Hepatol. 2020;26(3):280-293.
- Fecal microbiota transplantation in alcohol related liver diseases
- Saggere Muralikrishna Shasthry
- Clin Mol Hepatol. 2020;26(3):294-301.
- Editorials Is liver biopsy still useful in the era of non-invasive tests?
- Tae Seop Lim, Ja Kyung Kim
- Clin Mol Hepatol. 2020;26(3):302-304.
- Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
- Sojung Han, Do Young Kim
- Clin Mol Hepatol. 2020;26(3):305-308.
- Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
- So Yeon Kim
- Clin Mol Hepatol. 2020;26(3):309-311.
- Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
- Byoung Kuk Jang
- Clin Mol Hepatol. 2020;26(3):312-314.
- Low-level viremia in patients undergoing antiviral therapy: Does it indicate time for a change?
- Jung Hee Kim, Dong Hyun Sinn
- Clin Mol Hepatol. 2020;26(3):315-317.
- Original Articles Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years
- Young Chang, Jun Il Kim, Bora Lee, Sang Gyune Kim, Min Jung Jung, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Jeong-Ju Yoo
- Clin Mol Hepatol. 2020;26(3):318-327.
- Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
- Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Tae-You Kim, Yoon Jun Kim
- Clin Mol Hepatol. 2020;26(3):328-339.
- Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
- Sunyoung Lee, Seung-seob Kim, Dong ryul Chang, Hyerim Kim, Myeong-Jin Kim
- Clin Mol Hepatol. 2020;26(3):340-351.
- Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
- Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn
- Clin Mol Hepatol. 2020;26(3):352-363.
- Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir
- Seung Bum Lee, Joonho Jeong, Jae Ho Park, Seok Won Jung, In Du Jeong, Sung-Jo Bang, Jung Woo Shin, Bo Ryung Park, Eun Ji Park, Neung Hwa Park
- Clin Mol Hepatol. 2020;26(3):364-375.
- Letters to the Editor How does low-level viremia affect the prognosis of patients with chronic hepatitis B?
- Hye Won Lee, Beom Kyung Kim
- Clin Mol Hepatol. 2020;26(3):376-377.
- Macro-aspartate aminotransferase in a healthy woman
- Maria Lorubbio, Agostino Ognibene, Benedetta Salvadori, Alessandra Fanelli, Giacomo Laffi
- Clin Mol Hepatol. 2020;26(3):378-381.